Microsurgery

Galen Robotics Announces Over-Subscribed $15 Million Series A To Advance Next Phase in Surgical Robotics

Retrieved on: 
Tuesday, November 1, 2022
Surgeon, Robotics, Microsurgery, Neurosurgery, COVID, Research, Hospital, Johns Hopkins, Silicon, Public expenditure, Technology, FDA, Engineering, ENT, Johns Hopkins University, Spine, CA, Pharmaceutical industry, Medical device

BALTIMORE, Nov. 1, 2022 /PRNewswire/ -- Galen Robotics, the Digital-Surgery-as-a-Service ™ pioneer, today announced it has completed the 1st close for an oversubscribed Series A round with $15 million in funding, including investment from Ambix Healthcare Partners, from Menlo Park, CA.

Key Points: 
  • Galen plans to level the surgical playing field by erasing large capital expenditures associated with today's surgical robots.
  • Galen Robotics will be the first surgical robotics company to launch as "as-a-service" using the per-usage disposable model.
  • Termed Digital-Surgery-as-a-Service, is a new approach to surgical robotics, clearing the way to capture surgical data and promote continuous improvements of surgical techniques, outcomes, and the training of residents.
  • Galen Robotics was founded in 2016, bringing together Silicon Valley and the early work and research in surgical robotics at Johns Hopkins University.Galen Robotics is headquartered in Baltimore, Maryland.

ZEISS Microscopy Launches New Interactive Microsite

Retrieved on: 
Tuesday, October 25, 2022
Consumer, Health, Cell biology, Metal, Electronics, Microscopy, Carbon footprint, Natural Resources, Smart products, Ophthalmology, Science, Light, Education, Neuroscience, Vision, Carbon, Research, Microsurgery, Investment, Eye, Technology, Knowledge, Good Service Medal, Gold, Geology, Industry, Foundation, Carl-Zeiss-Stiftung, Travel, Communication, Carl Zeiss AG, National Institute of Metrology Standardization and Industrial Quality, Solution, ZEISS, Microscope, Video game

WHITE PLAINS, N.Y., Oct. 25, 2022 /PRNewswire/ -- ZEISS Research Microscopy Solutions announced its new microsite featuring nine researchers and 24 areas of study, to celebrate the amazing breakthroughs these scientists are achieving with ZEISS instruments. This virtual component is the at-home extension of their new interactive touchscreen experience recently debuted at ZEISS tradeshows. The microsite's web interface allows for an intuitive interaction to explore microscopic discoveries and will grow with more research breakthroughs to come. The microsite will allow the user to see some of what is featured during microscopy events.

Key Points: 
  • WHITE PLAINS, N.Y., Oct. 25, 2022 /PRNewswire/ --ZEISS Research Microscopy Solutions announced its new microsite featuring nine researchers and 24 areas of study, to celebrate the amazing breakthroughs these scientists are achieving with ZEISS instruments.
  • The microsite will allow the user to see some of what is featured during microscopy events.
  • This microsite is a way to give that same visibility of the incredible research they do to anyone interested in science," said Joseph Huff, Head of Marketing, ZEISS Microscopy, North America.
  • ZEISS Research Microscopy Solutions is the world's only one-stop manufacturer of light, electron, X-ray and ion microscope systems and offers solutions for correlative microscopy.

ZEISS celebrates grand opening of Quality Excellence Center in Wixom, Michigan

Retrieved on: 
Monday, October 17, 2022
Consumer, Health, ZEISS, National Institute of Metrology Standardization and Industrial Quality, Aerospace, Aircraft, Smart products, Ophthalmology, Science, Golden Joystick Awards, Software maintenance, Solution, IQR, LLC, Plastic, 3D, Research, Microsurgery, Multimedia, Investment, Lunch, Technology, CT, Learning, Industry, Foundation, Carl-Zeiss-Stiftung, Electric car, Carl Zeiss AG, GOM, Leadership, Telescopic sight

LYON TOWNSHIP, Mich., Oct. 17, 2022 /PRNewswire/ -- With the Grand Opening event, ZEISS has officially unveiled its state-of-the-art site near Detroit.

Key Points: 
  • LYON TOWNSHIP, Mich., Oct. 17, 2022 /PRNewswire/ -- With the Grand Opening event, ZEISS has officially unveiled its state-of-the-art site near Detroit.
  • The new facility for the Industrial Quality and Research(IQR) segment of ZEISS, is representedin the USA by Carl Zeiss Industrial Quality Solutions, LLC.
  • In addition, ZEISS Industrial Quality Solutions offers a broad global spectrum of customer services with ZEISS Quality Excellence Centers close to its customers.
  • ZEISS Industrial Quality Solutions is part of the Industrial Quality & Research segment.

Top Beverly Hills Plastic Surgeon, Dr. John Anastasatos Honored by Who is Who International for Contributions in Plastic Surgery

Retrieved on: 
Wednesday, October 12, 2022
CA, A Call for Unity, Congress, U.S. News & World Report, Woman, Science, Who, Rhinoplasty, Birmingham, Brown University, Man, Microsurgery, Character, United States Congress, University, LOS, Columbia University, Breast augmentation, Social responsibility, News, American Society for Aesthetic Plastic Surgery, Entrepreneurship, Dentistry

LOS ANGELES, Oct. 12, 2022 /PRNewswire-PRWeb/ -- The Who is Who International Awards 2022 selected Dr. John Anastasatos for the distinguished "World Eminent Man of Aesthetic Plastic Surgery" award, and he was recognized at the event ceremony that took place on Sept. 22, 2022, in Greece. The Who is Who International Awards celebrate prominent men and women leaders whose character and work create a positive impact on the present and future in the fields of academia, arts, entrepreneurship, science and social responsibility. Their focus lies on achieving friendships between nations, human charitable goals and environmental protection through business networking and the development of diplomatic relations. Dr. Anastasatos was an honors graduate of Brown University and trained in general and plastic surgery at Columbia University in NYC and additionally in plastic surgery and microsurgery at the University of Alabama at Birmingham. For the last 15 years, Dr. John Anastasatos has owned and operated one of the largest and most successful plastic surgery clinics in Beverly Hills, "Los Angeles Plastic Surgery," and since 2021, he has been operating his own clinic in Athens, Greece.

Key Points: 
  • Dr. Anastasatos was an honors graduate of Brown University and trained in general and plastic surgery at Columbia University in NYC and additionally in plastic surgery and microsurgery at the University of Alabama at Birmingham.
  • For the last 15 years, Dr. John Anastasatos has owned and operated one of the largest and most successful plastic surgery clinics in Beverly Hills, " Los Angeles Plastic Surgery ," and since 2021, he has been operating his own clinic in Athens, Greece.
  • The United States Congress has even honored him for his contributions to plastic surgery and charity service.
  • To schedule a consultation with Dr. John Anastasatos or for more information on his practice locations in Beverly Hills, CA, or Athens, Greece, please call (310) 888-4048, or visit his website http://www.LosAngelesPlasticSurgery.com .

Ultivue and ZEISS to Co-Market Complete Solution for Spatial Phenomics

Retrieved on: 
Wednesday, October 12, 2022
Consumer, Health, Cros, Smart products, Ophthalmology, Science, Workflow, Light, Education, LLC, Drug development, Research, Microsurgery, Multimedia, Investment, Partnership, Precision medicine, Technology, Acquisition, Industry, CEO, Foundation, Carl-Zeiss-Stiftung, Carl Zeiss AG, National Institute of Metrology Standardization and Industrial Quality, Solution, ZEISS, Microscope, Medical imaging

WHITE PLAINS, N.Y. and CAMBRIDGE, Mass., Oct. 12, 2022 /PRNewswire/ -- Carl Zeiss Microscopy, LLC, today announced that it has entered into an agreement with Ultivue Inc. to co-market Ultivue's multiplex biomarker assays for tissue phenotyping with the ZEISS Axioscan whole slide imaging system for data acquisition and analysis. The partnership will bring a streamlined solution from tissue preparation to image acquisition and analysis for applications in cancer biology, immunology, and drug development for researchers in academia, biotech, pharma, and CROs.

Key Points: 
  • With unprecedented signal-to-noise and options for pre-designed panels or customized panels, Ultivue solutions are designed to label tissues for in-depth data mining for spatial phenomics.
  • With this collaboration, Ultivue and ZEISS will offer researchers a faster time to results from tissue labeling to image acquisition through analysis.
  • "At Ultivue, we have successfully scanned thousands of tissue sections stained with our multiplex assays with the ZEISS Axioscan to serve our biopharma customers.
  • We are excited to deepen our relationship with ZEISS to further optimize the interplay of Ultivue assays and ZEISS instruments," said Jacques Corriveau President and CEO of Ultivue.

ZEISS Receives FDA Clearance for MTLawton - A New Generation of Bipolar Forceps for Electrosurgery

Retrieved on: 
Monday, October 10, 2022
Barrow Neurological Institute, Congress, Percussion section, Health technology, Patient, Surgeon, Microsurgery, Congress of Neurological Surgeons, Acquisition, MD, Department, Hemostasis, CEO, Neurosurgery, Chair, CNS, Dissection, Pectus carinatum, FDA, Electrosurgery, Solution, ZEISS, Dentistry, Pharmaceutical industry

JENA, Germany, Oct. 10, 2022 /PRNewswire/ -- ZEISS Medical Technology announced that it has received 510(k) clearance from the FDA for MTLawton™. These new disposable bipolar forceps are made from a special copper-base alloy and potentially reduce tissue adhesion and subsequent charring during dissection of tissue. Thanks to the extended shaft, the forceps also reduce visual restrictions in the surgical field and help surgeons to be efficient during electrosurgical procedures.

Key Points: 
  • JENA, Germany, Oct. 10, 2022 /PRNewswire/ --ZEISS Medical Technology announced that it has received 510(k) clearance from the FDA for MTLawton.
  • The development of the new bipolar forceps from ZEISS is based on close collaboration with Michael T. Lawton, one of the world's leading neurosurgeons.
  • "The MTLawton Disposable Bipolar Forceps are a real advance in electrosurgery over aluminum forceps.
  • MTLawton from ZEISS takes non-stick technology to a whole new level by introducing our bipolar forceps made of a special copper-base alloy.

Promaxo Announces Six System Sales in the Third Quarter 2022

Retrieved on: 
Tuesday, October 4, 2022
Urinary bladder, GLOBE, Hospital, Physician, Robotics, Urology Center of Westchester, Technology, Associate, American Urological Association, CEO, Pain, Infertility, FDA, Longitudinal wave, MRI, Karl, Urethra, Male, HIFU, Partnership, Kidney, Microsurgery, Erectile dysfunction, Sale, University, Patient, Exocrine gland, Diagnosis, Magnetic resonance imaging, Village, Scar, Prostate cancer, Cryosurgery, AI, Company, Awareness, Medical imaging, Pharmaceutical industry, Central Texas, Urology, Central Florida

OAKLAND, Calif., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Promaxo, Inc. (Promaxo or the Company), a medical imaging, robotics, and AI technology company, today announced the sale of six systems in the United States in the third quarter ending September 30, 2022.

Key Points: 
  • OAKLAND, Calif., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Promaxo, Inc. (Promaxo or the Company), a medical imaging, robotics, and AI technology company, today announced the sale of six systems in the United States in the third quarter ending September 30, 2022.
  • The system sales included both operating lease and revenue share agreements with physician practices in Florida, New Jersey, and Texas.
  • Promaxos single-sided MRI with AI based imaging system, FDA cleared for in-office use, empowers practices and hospitals to accurately and seamlessly guide prostate interventions under the Promaxo MRI system.
  • The Company has formed numerous long-term and strategic partnerships with investor groups and corporation as it drives commercialization of the Promaxo MRI system.

Posterity Health, the Only Virtual Male Fertility Center of Excellence, Announces Regional Expansion Into Texas, Oklahoma and Arkansas

Retrieved on: 
Tuesday, October 4, 2022
Other Health, Software, Men, General Health, Internet, Family, Telemedicine, Virtual Medicine, Consumer, Technology, Parenting, Baby, Maternity, Health, Men's Health, Male, Female, University of Texas Southwestern Medical Center, Weill Cornell Medicine, Fertility, Pure, Infertility, Medicine, Health, OBGYN, University of Arkansas for Medical Sciences, Penn State College of Information Sciences and Technology, University, REI, Microsurgery, Andrology, Patient, Yale University, Attention, Pregnancy, Illinois College, USCF, Founder, Birth control, Urology

Posterity Health , the only virtual male fertility center of excellence that offers personalized care, educational resources, and effective treatments to address male fertility, announces regional expansion into Texas, Oklahoma and Arkansas.

Key Points: 
  • Posterity Health , the only virtual male fertility center of excellence that offers personalized care, educational resources, and effective treatments to address male fertility, announces regional expansion into Texas, Oklahoma and Arkansas.
  • Posterity Healths mission to bring equity to fertility by providing access to inclusive male fertility care to all couples trying to conceive.
  • The company offers a combination of virtual visits, at-home diagnostics and in-person consults to help assess and improve a males fertility status.
  • Services include male fertility assessments, diagnostic workups, vasectomies and vasectomy reversals, surgical sperm extractions and varicocele repairs, as well as recurrent pregnancy loss consults.

Medical Microinstruments Introduces Even Smaller Robotic Instruments to Address Complex Supermicrosurgery

Retrieved on: 
Wednesday, September 7, 2022
Artery, Lymphedema, CEO, Cancer, RA, DDS, Oral, Hand, Suture, Oral and maxillofacial surgery, Robotics, Supermicro, Tongue, Department, Union, Microsurgery, Vein, MD, Surgeon, Frasier, MMI, Patient, Dentistry, EU, Biostar

PISA, Italy, Sept. 7, 2022 /PRNewswire/ -- Medical Microinstruments, Inc. (MMI), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced the launch of its new Supermicro NanoWrist® instruments for use with the Symani® Surgical System, developed specifically to address the challenges of microsurgery. The new supermicro needle holder and dilator were recently used in clinical procedures in Zürich, Florence, and Salzburg, with successful patient outcomes.

Key Points: 
  • "We've already seen the benefits of Symani and the NanoWrist instruments in improving dexterity and control," said Dr. Enzinger.
  • "The new supermicro instrument tips are even smaller and more refined, making it significantly easier to precisely connect vessels under one millimeter in diameter.
  • Medical Microinstruments, Inc. (MMI) was founded in 2015 near Pisa, Italy to enhance surgical performance through the development of a robotic system that enables surgeons to achieve better outcomes in microsurgery.
  • The Symani Surgical System combines proprietary innovations including the world's smallest wristed microinstruments as well as tremor-reducing and motion-scaling technologies.

Medical Microinstruments Introduces Even Smaller Robotic Instruments to Address Complex Supermicrosurgery

Retrieved on: 
Wednesday, September 7, 2022
Artery, Lymphedema, CEO, Cancer, RA, DDS, Oral, Hand, Suture, Oral and maxillofacial surgery, Robotics, Supermicro, Tongue, Department, Union, Microsurgery, Vein, MD, Surgeon, Frasier, MMI, Patient, Dentistry, EU, Biostar

PISA, Italy, Sept. 7, 2022 /PRNewswire/ -- Medical Microinstruments, Inc. (MMI), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced the launch of its new Supermicro NanoWrist® instruments for use with the Symani® Surgical System, developed specifically to address the challenges of microsurgery. The new supermicro needle holder and dilator were recently used in clinical procedures in Zürich, Florence, and Salzburg, with successful patient outcomes.

Key Points: 
  • "We've already seen the benefits of Symani and the NanoWrist instruments in improving dexterity and control," said Dr. Enzinger.
  • "The new supermicro instrument tips are even smaller and more refined, making it significantly easier to precisely connect vessels under one millimeter in diameter.
  • Medical Microinstruments, Inc. (MMI) was founded in 2015 near Pisa, Italy to enhance surgical performance through the development of a robotic system that enables surgeons to achieve better outcomes in microsurgery.
  • The Symani Surgical System combines proprietary innovations including the world's smallest wristed microinstruments as well as tremor-reducing and motion-scaling technologies.